A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANZ, Felipe de Lara et al. Fundamentos da terapia celular. Clínica Médica. Tradução . São Paulo: Atheneu, 2013. . . Acesso em: 05 nov. 2024.
APA
Janz, F. de L., Debes, A. de A., Sekiya, E. J. S., Bydlowski, S. P., & Alves, A. (2013). Fundamentos da terapia celular. In Clínica Médica. São Paulo: Atheneu.
NLM
Janz F de L, Debes A de A, Sekiya EJS, Bydlowski SP, Alves A. Fundamentos da terapia celular. In: Clínica Médica. São Paulo: Atheneu; 2013. [citado 2024 nov. 05 ]
Vancouver
Janz F de L, Debes A de A, Sekiya EJS, Bydlowski SP, Alves A. Fundamentos da terapia celular. In: Clínica Médica. São Paulo: Atheneu; 2013. [citado 2024 nov. 05 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Jorge Luis Maria e LEVY, Debora e BYDLOWSKI, Sergio Paulo. Princípios da terapia gênica. Clínica Médica. Tradução . São Paulo: Atheneu, 2013. . . Acesso em: 05 nov. 2024.
APA
Ruiz, J. L. M., Levy, D., & Bydlowski, S. P. (2013). Princípios da terapia gênica. In Clínica Médica. São Paulo: Atheneu.
NLM
Ruiz JLM, Levy D, Bydlowski SP. Princípios da terapia gênica. In: Clínica Médica. São Paulo: Atheneu; 2013. [citado 2024 nov. 05 ]
Vancouver
Ruiz JLM, Levy D, Bydlowski SP. Princípios da terapia gênica. In: Clínica Médica. São Paulo: Atheneu; 2013. [citado 2024 nov. 05 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BYDLOWSKI, Sergio Paulo. Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Revista brasileira de hematologia e hemoterapia, v. 35, n. 5, p. 313, 2013Tradução . . Disponível em: https://doi.org/10.5581/1516-8484.20130101. Acesso em: 05 nov. 2024.
APA
Bydlowski, S. P. (2013). Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Revista brasileira de hematologia e hemoterapia, 35( 5), 313. doi:10.5581/1516-8484.20130101
NLM
Bydlowski SP. Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years [Internet]. Revista brasileira de hematologia e hemoterapia. 2013 ; 35( 5): 313.[citado 2024 nov. 05 ] Available from: https://doi.org/10.5581/1516-8484.20130101
Vancouver
Bydlowski SP. Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years [Internet]. Revista brasileira de hematologia e hemoterapia. 2013 ; 35( 5): 313.[citado 2024 nov. 05 ] Available from: https://doi.org/10.5581/1516-8484.20130101
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAEDA, Nair Y. et al. Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A14140?sid=e4c2e5de-fc3f-4165-99b8-99246fd5c775. Acesso em: 05 nov. 2024. , 2013
APA
Maeda, N. Y., Costa, H. G., Siqueira, A. W., Soares, R. P., Mesquita, S., Bydlowski, S. P., et al. (2013). Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A14140?sid=e4c2e5de-fc3f-4165-99b8-99246fd5c775
NLM
Maeda NY, Costa HG, Siqueira AW, Soares RP, Mesquita S, Bydlowski SP, Miura N, Lopes AA. Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 nov. 05 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A14140?sid=e4c2e5de-fc3f-4165-99b8-99246fd5c775
Vancouver
Maeda NY, Costa HG, Siqueira AW, Soares RP, Mesquita S, Bydlowski SP, Miura N, Lopes AA. Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 nov. 05 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A14140?sid=e4c2e5de-fc3f-4165-99b8-99246fd5c775
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Jorge L. M. et al. Interrelationship between ATP-binding cassette transporters and oxysterols. Biochemical Pharmacology, v. 86, n. 1, p. 80-88, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2013.02.033. Acesso em: 05 nov. 2024.
APA
Ruiz, J. L. M., Fernandes, L. R., Levy, D., & Bydlowski, S. P. (2013). Interrelationship between ATP-binding cassette transporters and oxysterols. Biochemical Pharmacology, 86( 1), 80-88. doi:10.1016/j.bcp.2013.02.033
NLM
Ruiz JLM, Fernandes LR, Levy D, Bydlowski SP. Interrelationship between ATP-binding cassette transporters and oxysterols [Internet]. Biochemical Pharmacology. 2013 ; 86( 1): 80-88.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.bcp.2013.02.033
Vancouver
Ruiz JLM, Fernandes LR, Levy D, Bydlowski SP. Interrelationship between ATP-binding cassette transporters and oxysterols [Internet]. Biochemical Pharmacology. 2013 ; 86( 1): 80-88.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.bcp.2013.02.033
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Rosangela P. S. et al. Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease. Clinics, v. 68, n. 4, p. 531-536, 2013Tradução . . Disponível em: https://doi.org/10.6061/clinics/2013(04)15. Acesso em: 05 nov. 2024.
APA
Soares, R. P. S., Bydlowski, S. P., Jatene, M. B., Hironaka, J. F., & Lopes, A. A. (2013). Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease. Clinics, 68( 4), 531-536. doi:10.6061/clinics/2013(04)15
NLM
Soares RPS, Bydlowski SP, Jatene MB, Hironaka JF, Lopes AA. Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease [Internet]. Clinics. 2013 ; 68( 4): 531-536.[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2013(04)15
Vancouver
Soares RPS, Bydlowski SP, Jatene MB, Hironaka JF, Lopes AA. Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease [Internet]. Clinics. 2013 ; 68( 4): 531-536.[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2013(04)15
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STERN, Ana Carolina et al. Starvation promotes decrease of survivin gene expression in human lymphoma cells lines. Experimental Hematology. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2013
APA
Stern, A. C., Levy, D., Ruiz, J. L., & Bydlowski, S. (2013). Starvation promotes decrease of survivin gene expression in human lymphoma cells lines. Experimental Hematology. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Stern AC, Levy D, Ruiz JL, Bydlowski S. Starvation promotes decrease of survivin gene expression in human lymphoma cells lines. Experimental Hematology. 2013 ; 41 S51 res. P1110.[citado 2024 nov. 05 ]
Vancouver
Stern AC, Levy D, Ruiz JL, Bydlowski S. Starvation promotes decrease of survivin gene expression in human lymphoma cells lines. Experimental Hematology. 2013 ; 41 S51 res. P1110.[citado 2024 nov. 05 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Juliana et al. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug?. Anti-Cancer Agents in Medicinal Chemistry, v. 13, n. 1, p. 186-192, 2013Tradução . . Disponível em: https://doi.org/10.2174/187152013804487416. Acesso em: 05 nov. 2024.
APA
Pereira, J., Levy, D., Ruiz, J. L. M., Brocardo, G. A., Ferreira, K. A., Costa, R. O., et al. (2013). Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? Anti-Cancer Agents in Medicinal Chemistry, 13( 1), 186-192. doi:10.2174/187152013804487416
NLM
Pereira J, Levy D, Ruiz JLM, Brocardo GA, Ferreira KA, Costa RO, Queiroz RG, Maria DA, Hallack Neto AE, Chamone DAF, Bydlowski SP. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2013 ; 13( 1): 186-192.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/187152013804487416
Vancouver
Pereira J, Levy D, Ruiz JLM, Brocardo GA, Ferreira KA, Costa RO, Queiroz RG, Maria DA, Hallack Neto AE, Chamone DAF, Bydlowski SP. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2013 ; 13( 1): 186-192.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/187152013804487416
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Jorge Luis et al. Conditioned medium from human mesenchymal stem cells (MSC) from different sources induce proliferation or cell death in HepG-2 and Jurkat cancer cells depending on its origin. Experimental Hematology. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2013
APA
Ruiz, J. L., Levy, D., Carvalho, A. C., Sekiya, E., & Bydlowski, S. (2013). Conditioned medium from human mesenchymal stem cells (MSC) from different sources induce proliferation or cell death in HepG-2 and Jurkat cancer cells depending on its origin. Experimental Hematology. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Ruiz JL, Levy D, Carvalho AC, Sekiya E, Bydlowski S. Conditioned medium from human mesenchymal stem cells (MSC) from different sources induce proliferation or cell death in HepG-2 and Jurkat cancer cells depending on its origin. Experimental Hematology. 2013 ; 41 S75 res. P1199.[citado 2024 nov. 05 ]
Vancouver
Ruiz JL, Levy D, Carvalho AC, Sekiya E, Bydlowski S. Conditioned medium from human mesenchymal stem cells (MSC) from different sources induce proliferation or cell death in HepG-2 and Jurkat cancer cells depending on its origin. Experimental Hematology. 2013 ; 41 S75 res. P1199.[citado 2024 nov. 05 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, R. P. S. et al. Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease. Brazilian Journal of Medical and Biological Research, v. 46, n. 4, p. 375-381, 2013Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20122603. Acesso em: 05 nov. 2024.
APA
Soares, R. P. S., Bydlowski, S. P., Nascimento, N. M., Thomaz, A. M., Bastos, E. N. M., & Lopes, A. A. (2013). Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease. Brazilian Journal of Medical and Biological Research, 46( 4), 375-381. doi:10.1590/1414-431X20122603
NLM
Soares RPS, Bydlowski SP, Nascimento NM, Thomaz AM, Bastos ENM, Lopes AA. Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease [Internet]. Brazilian Journal of Medical and Biological Research. 2013 ; 46( 4): 375-381.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/1414-431X20122603
Vancouver
Soares RPS, Bydlowski SP, Nascimento NM, Thomaz AM, Bastos ENM, Lopes AA. Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease [Internet]. Brazilian Journal of Medical and Biological Research. 2013 ; 46( 4): 375-381.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/1414-431X20122603
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SINI, B. C. et al. Frequency of lymphomas in a cohort of patients with common variable immunodeficiency. Journal of Clinical Immunology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://link.springer.com/article/10.1007%2Fs10875-013-9869-2. Acesso em: 05 nov. 2024. , 2013
APA
Sini, B. C., Kokron, C. M., Levy, D., Pereira, J., Oliveira, A. K. B., Cohon, A., et al. (2013). Frequency of lymphomas in a cohort of patients with common variable immunodeficiency. Journal of Clinical Immunology. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1007/s10875-013-9869-2
NLM
Sini BC, Kokron CM, Levy D, Pereira J, Oliveira AKB, Cohon A, Kalil J, Bydlowski SP, Barros MT. Frequency of lymphomas in a cohort of patients with common variable immunodeficiency [Internet]. Journal of Clinical Immunology. 2013 ; 33( 3): 684.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007%2Fs10875-013-9869-2
Vancouver
Sini BC, Kokron CM, Levy D, Pereira J, Oliveira AKB, Cohon A, Kalil J, Bydlowski SP, Barros MT. Frequency of lymphomas in a cohort of patients with common variable immunodeficiency [Internet]. Journal of Clinical Immunology. 2013 ; 33( 3): 684.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007%2Fs10875-013-9869-2
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Adilson Kleber et al. Anti-Angiogenic and anti-Metastatic activity of synthetic phosphoethanolamine. PLOS ONE, v. 8, n. 3, p. 14 , 2013Tradução . . Disponível em: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057937. Acesso em: 05 nov. 2024.
APA
Ferreira, A. K., Freitas, V. M., Levy, D., Ruiz, J. L. M., Bydlowski, S. P., Rici, R. E. G., et al. (2013). Anti-Angiogenic and anti-Metastatic activity of synthetic phosphoethanolamine. PLOS ONE, 8( 3), 14 . doi:10.1371/journal.pone.0057937
NLM
Ferreira AK, Freitas VM, Levy D, Ruiz JLM, Bydlowski SP, Rici REG, Ribeiro Filho OM, Chierice GO, Maria DA. Anti-Angiogenic and anti-Metastatic activity of synthetic phosphoethanolamine [Internet]. PLOS ONE. 2013 ; 8( 3): 14 .[citado 2024 nov. 05 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057937
Vancouver
Ferreira AK, Freitas VM, Levy D, Ruiz JLM, Bydlowski SP, Rici REG, Ribeiro Filho OM, Chierice GO, Maria DA. Anti-Angiogenic and anti-Metastatic activity of synthetic phosphoethanolamine [Internet]. PLOS ONE. 2013 ; 8( 3): 14 .[citado 2024 nov. 05 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057937
